Sonstiges: |
- Nachgewiesen in: MEDLINE
- Sprachen: English
- Publication Type: Journal Article
- Language: English
- [Endocrine] 2022 Apr; Vol. 76 (1), pp. 151-161. <i>Date of Electronic Publication: </i>2022 Jan 14.
- MeSH Terms: Adrenal Hyperplasia, Congenital* / genetics ; Hypertension* / epidemiology ; Hypertension* / genetics ; Hypokalemia* ; China / epidemiology ; Humans ; Incidence ; Mixed Function Oxygenases / genetics ; Mutation ; Steroid 17-alpha-Hydroxylase / genetics
- References: D. EL-Maouche, W. Arlt, D.P. Merke, Congenital adrenal hyperplasia. Lancet 390(10108), 2194–2210 (2017). (PMID: 10.1016/S0140-6736(17)31431-9) ; C.E. Kater, E.G. Biglieri, Disorders of steroid 17 alpha-hydroxylase deficiency. Endocrinol. Metab. Clin. North Am. 23(2), 341–357 (1994). (PMID: 10.1016/S0889-8529(18)30101-4) ; W.L. Miller, R.J. Auchus, D.H. Geller, The regulation of 17,20 lyase activity. Steroids 62(1), 133–142 (1997). (PMID: 10.1016/S0039-128X(96)00172-9) ; B.C. Chung, J. Picado-Leonard, M. Haniu et al. Cytochrome P450c17 (steroid 17 alpha-hydroxylase/17,20 lyase): cloning of human adrenal and testis cDNAs indicates the same gene is expressed in both tissues. Proc. Natl. Acad. Sci. U S A. 84(2), 407–411 (1987). (PMID: 10.1073/pnas.84.2.407) ; R.J. Auchus, Steroid 17-hydroxylase and 17,20-lyase deficiencies, genetic and pharmacologic. J. Steroid. Biochem. Mol. Biol. 165(Pt A), 71–78 (2017). (PMID: 10.1016/j.jsbmb.2016.02.002) ; T. Yanase, E.R. Simpson, M.R. Waterman, 17 alpha-hydroxylase/17,20-lyase deficiency: from clinical investigation to molecular definition. Endocr. Rev. 12(1), 91–108 (1991). (PMID: 10.1210/edrv-12-1-91) ; R. Fontenele, M. Costa-Santos, C.E. Kater, 17alpha-hydroxylase deficiency is an underdiagnosed disease: high frequency of misdiagnoses in a large cohort of brazilian patients. Endocr. Pract. 24(2), 170–178 (2018). (PMID: 10.4158/EP171987.OR) ; L. Hinz, D. Pacaud, G. Kline, Congenital adrenal hyperplasia causing hypertension: an illustrative review. J. Hum. Hypertens. 32(2), 150–157 (2018). (PMID: 10.1038/s41371-017-0002-5) ; B. Williams, G. Mancia, W. Spiering et al. 2018 ESC/ESH guidelines for the management of arterial hypertension. Eur. Heart J. 39(33), 3021–3104 (2018). (PMID: 10.1093/eurheartj/ehy339) ; Unger T., Borghi C., Charchar F. et al. 2020 International society of hypertension global hypertension practice guidelines. J. Hypertens. 38, 982–1004 (2020). ; S.V. Greve, M.K. Blicher, T. Sehestedt et al. Effective risk stratification in patients with moderate cardiovascular risk using albuminuria and atherosclerotic plaques in the carotid arteries. J. Hypertens. 33(8), 1563–1570 (2015). (PMID: 10.1097/HJH.0000000000000584) ; P. Perrone-Filardi, A. Coca, M. Galderisi et al. Noninvasive cardiovascular imaging for evaluating subclinical target organ damage in hypertensive patients: a consensus article from the European Association of Cardiovascular Imaging, the European Society of Cardiology Council on Hypertension and the Euro. J. Hypertens. 35(9), 1727–1741 (2017). (PMID: 10.1097/HJH.0000000000001396) ; B.H. Van Den Born, G.Y.H. Lip, J. Brguljan-Hitij et al. ESC council on hypertension position document on the management of hypertensive emergencies. Eur. Heart J. Cardiovasc. Pharmacother. 5(1), 37–46 (2019). (PMID: 10.1093/ehjcvp/pvy032) ; G. De Simone, R.B. Devereux, R. Izzo et al. Lack of reduction of left ventricular mass in treated hypertension: the strong heart study. J. Am. Heart Assoc. 2(3), e000144 (2013). (PMID: 10.1161/JAHA.113.000144) ; M.T. Lonnebakken, R.Izzo, C.Mancusi, et al. Left ventricular hypertrophy regression during antihypertensive treatment in an outpatient clinic (the Campania Salute Network). J. Am. Heart Assoc 6(3), e004152 (2017). (PMID: 10.1161/JAHA.116.004152) ; H. Triantafyllidi, D. Be Nas, A. Schoinas, et al. Hypertension-mediated organ damage regression associates with blood pressure variability improvement three years after successful treatment initiation in essential hypertension. J. Clin. Hypertens (Greenwich) 23(6), 1150–1158 (2021). (PMID: 10.1111/jch.14209) ; M. Zhang, S. Sun, Y. Liu et al. New, recurrent, and prevalent mutations: Clinical and molecular characterization of 26 Chinese patients with 17alpha-hydroxylase/17,20-lyase deficiency. J. Steroid Biochem. Mol. Biol. 150, 11–16 (2015). (PMID: 10.1016/j.jsbmb.2015.02.007) ; C.S. Marivania, C.E. Kater, R.J. Auchus, Two prevalent CYP17 mutations and genotype-phenotype correlations in 24 Brazilian patients with 17-Hydroxylase deficiency. J. Clin. Endocrinol. Metabol. 1, 49–60 (2004). ; X. Zhang, M. Zhang, Z. Zhao et al. Geographic variation in prevalence of adult obesity in China: results from the 2013–2014 national chronic disease and risk factor surveillance. Ann. Intern. Med. 172(4), 291–293 (2020). (PMID: 10.7326/M19-0477) ; F.J. Gennari, Hypokalemia. N. Engl. J. Med. 339(7), 451–458 (1998). (PMID: 10.1056/NEJM199808133390707) ; A.J. Viera, N. Wouk, Potassium disorders: hypokalemia and hyperkalemia. Am. Fam. Physician 92(6), 487–495 (2015). (PMID: 26371733) ; J. Ashurst, S.R. Sergent, B.R. Sergent, Evidence-based management of potassium disorders in the emergency department. Emerg. Med. Pract. 18(11), 1–24 (2016). (PMID: 27775507) ; Chinese Hypertension Prevention and Treatment Guidelines Revision Committee H U C, Cardiology Branch of Chinese Medical Association. Chinese Guidelines for the Prevention and Treatment of Hypertension (2018 Revised Edition). Chin J. Cardiovasc Med. 24(1), 25 (2009). ; C.A. Marsh, R.J. Auchus, Fertility in patients with genetic deficiencies of cytochrome P450c17 (CYP17A1): combined 17-hydroxylase/17,20-lyase deficiency and isolated 17,20-lyase deficiency. Fertil. Steril. 101(2), 317–322 (2014). (PMID: 10.1016/j.fertnstert.2013.11.011) ; Y.P. Wang, J. Li, J.X. Li et al. Three novel CYP17A1 gene mutations (A82D, R125X, and C442R) found in combined 17α-hydroxylase/17,20-lyase deficiency. Metabolism 60(10), 1386–1391 (2011). (PMID: 10.1016/j.metabol.2011.03.008) ; N. Laflamme, J.F. Leblanc, J. Mailloux et al. Mutation R96W in cytochrome P450c17 gene causes combined 17 alpha-hydroxylase/17-20-lyase deficiency in two French Canadian patients. J. Clin. Endocrinol. Metab. 81(1), 264–268 (1996). (PMID: 10.1210/jcem.81.1.8550762) ; N. Nájera, N. Garibay, Y. Pastrana et al. Loss of cytochrome P450 17A1 protein expression in a 17alpha-hydroxylase/17,20-lyase-deficient 46,XY female caused by two novel mutations in the CYP17A1 gene. Endocr. Pathol. 20(4), 249–255 (2009). (PMID: 10.1007/s12022-009-9088-9) ; E.L. Van Den Akker, J.W. Koper, A.L. Boehmer et al. Differential inhibition of 17alpha-hydroxylase and 17,20-lyase activities by three novel missense CYP17 mutations identified in patients with P450c17 deficiency. J. Clin. Endocrinol. Metab. 87(12), 5714–5721 (2002). (PMID: 10.1210/jc.2001-011880) ; Y.M. Kim, M. Kang, J.H. Choi et al. A review of the literature on common CYP17A1 mutations in adults with 17-hydroxylase/17,20-lyase deficiency, a case series of such mutations among Koreans and functional characteristics of a novel mutation. Metabolism 63(1), 42–49 (2014). (PMID: 10.1016/j.metabol.2013.08.015) ; K. Miura, K. Yasuda, T. Yanase et al. Mutation of cytochrome P-45017 alpha gene (CYP17) in a Japanese patient previously reported as having glucocorticoid-responsive hyperaldosteronism: with a review of Japanese patients with mutations of CYP17. J. Clin. Endocrinol. Metab. 81(10), 3797–3801 (1996). (PMID: 8855840) ; S. Ardhanari, R. Kannuswamy, K. Chaudhary et al. Mineralocorticoid and apparent mineralocorticoid syndromes of secondary hypertension. Adv. Chronic. Kidney Dis. 22(3), 185–195 (2015). (PMID: 10.1053/j.ackd.2015.03.002) ; H. Cui, F. Wang, L. Fan et al. Association factors of target organ damage: analysis of 17,682 elderly hypertensive patients in China. Chin Med. J. (Engl) 124(22), 3676–3681 (2011). ; F.F. Wei, Y. Li, L. Zhang et al. Association of target organ damage with 24-hour systolic and diastolic blood pressure levels and hypertension subtypes in untreated Chinese. Hypertension 63(2), 222–228 (2014). (PMID: 10.1161/HYPERTENSIONAHA.113.01940) ; H.E. Nelissen, M.E. Hendriks, F.W.N.M. Wit et al. Target organ damage among hypertensive adults in rural Nigeria: a cross-sectional study. J. Hypertens. 32(3), 487–494 (2014). (PMID: 10.1097/HJH.0000000000000056) ; S. Reungjui, C.A. Roncal, W. Sato et al. Hypokalemic nephropathy is associated with impaired angiogenesis. J. Am. Soc. Nephrol. 19(1), 125–134 (2008). (PMID: 10.1681/ASN.2007030261) ; A.S. Relman, W.B. Schwartz, The kidney in potassium depletion. Am. J. Med. 24(5), 764–773 (1958). (PMID: 10.1016/0002-9343(58)90379-6) ; T. Dyckner, Relation of cardiovascular disease to potassium and magnesium deficiencies. Am. J. Cardiol. 65(23), 44k–46k (1990). (PMID: 10.1016/0002-9149(90)91279-F) ; B.F. Palmer, D.J. Clegg, Physiology and pathophysiology of potassium homeostasis. Adv. Physiol. Educ. 40(4), 480–490 (2016). (PMID: 10.1152/advan.00121.2016)
- Contributed Indexing: Keywords: 17α-Hydroxylase/17,20-lyase deficiency; Hypertension; Hypertension-mediated organ damage
- Substance Nomenclature: EC 1.- (Mixed Function Oxygenases) ; EC 1.14.14.19 (Steroid 17-alpha-Hydroxylase)
- Entry Date(s): Date Created: 20220115 Date Completed: 20220408 Latest Revision: 20220515
- Update Code: 20240513
|